Yubo International Biotech Statistics
Yubo International Biotech (YBGJ) Stock Statistics & Valuation Metrics
Total Valuation
Yubo International Biotech has a market cap or net worth of $937.31K. The enterprise value is $867.54B.
- Market Cap
- $937.31K
- Enterprise Value
- $867.54B
Share Statistics
Yubo International Biotech has 170,416,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 170,416,340
- Owned by Insiders
- 63.23%
- Owned by Institutions
- ―
Financial Efficiency
Yubo International Biotech’s return on equity (ROE) is 0.55 and return on invested capital (ROIC) is 57.84%.
- Return on Equity (ROE)
- 0.55
- Return on Assets (ROA)
- -1.27
- Return on Invested Capital (ROIC)
- 57.84%
- Return on Capital Employed (ROCE)
- 0.61
- Revenue Per Employee
- 9,599.357
- Profits Per Employee
- -77.09K
- Employee Count
- 14
- Asset Turnover
- 0.16
- Inventory Turnover
- 5.25
Valuation Ratios
The current PE Ratio of Yubo International Biotech is -0.96. Yubo International Biotech’s PEG ratio is -0.02.
- PE Ratio
- -0.96
- PS Ratio
- 6.97
- PB Ratio
- -0.33
- Price to FCF
- -80.45
- Price to Operating Cash Flow
- -80.46
- PEG Ratio
- -0.02
Income Statement
In the last 12 months, Yubo International Biotech had revenue of 134.39K and earned -1.08M in profits. Earnings per share was -0.01.
- Revenue
- 134.39K
- Gross Profit
- 8,165
- Operating Income
- -1.19M
- Pretax Income
- -1.19M
- Net Income
- -1.08M
- EBITDA
- -1.01M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -11.65K and capital expenditures 0, giving a free cash flow of -11.65K billion.
- Operating Cash Flow
- -11.65K
- Free Cash Flow
- -11.65K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Yubo International Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.24%
- Earnings Yield
- -90.20%
Stock Price Statistics
- Beta
- -0.16
- 52-Week Price Change
- -28.57%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 23.40
- Average Volume (3m)
- 2,220
Financial Position
Yubo International Biotech as a current ratio of 0.24, with Debt / Equity ratio of -4.03%
- Current Ratio
- 0.24
- Quick Ratio
- 0.23
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.07
- Interest Coverage Ratio
- 4887.64
Taxes
In the past 12 months, Yubo International Biotech has paid -108.69K in taxes.
- Income Tax
- -108.69K
- Effective Tax Rate
- 0.09
Enterprise Valuation
Yubo International Biotech EV to EBITDA ratio is -0.96, with an EV/FCF ratio of -79.64.
- EV to Sales
- 6.90
- EV to EBITDA
- -0.96
- EV to Free Cash Flow
- -79.64
- EV to Operating Cash Flow
- -79.64
Balance Sheet
Yubo International Biotech has $9,465.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $9,465.00 billion.
- Cash & Marketable Securities
- $9,465.00
- Total Debt
- $0.00
- Net Cash
- $9,465.00
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.02
Margins
Gross margin is 37.77%, with operating margin of -663.80%, and net profit margin of -629.09%.
- Gross Margin
- 37.77%
- Operating Margin
- -663.80%
- Pretax Margin
- -690.69%
- Net Profit Margin
- -629.09%
- EBITDA Margin
- -722.11%
- EBIT Margin
- -779.31%
Analyst Forecast
The average price target for Yubo International Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―

